Judy L. Thompson, Ph.D. - Publications

Affiliations: 
2006 University of Pittsburgh, Pittsburgh, PA, United States 

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Girgis RR, Van Snellenberg JX, Glass A, Kegeles LS, Thompson JL, Wall M, Cho RY, Carter CS, Slifstein M, Abi-Dargham A, Lieberman JA. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia. Journal of Psychopharmacology (Oxford, England). PMID 26966119 DOI: 10.1177/0269881116636120  0.36
2015 Slifstein M, van de Giessen E, Van Snellenberg J, Thompson JL, Narendran R, Gil R, Hackett E, Girgis R, Ojeil N, Moore H, D'Souza D, Malison RT, Huang Y, Lim K, Nabulsi N, et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. Jama Psychiatry. 72: 316-24. PMID 25651194 DOI: 10.1001/jamapsychiatry.2014.2414  0.36
2015 Van Snellenberg JX, Slifstein M, Read C, Weber J, Thompson JL, Wager TD, Shohamy D, Abi-Dargham A, Smith EE. Dynamic shifts in brain network activation during supracapacity working memory task performance. Human Brain Mapping. 36: 1245-64. PMID 25422039 DOI: 10.1002/hbm.22699  0.36
2014 van de Giessen E, Rosell DR, Thompson JL, Xu X, Girgis RR, Ehrlich Y, Slifstein M, Abi-Dargham A, Siever LJ. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB. Journal of Psychiatric Research. 58: 147-54. PMID 25145808 DOI: 10.1016/j.jpsychires.2014.07.025  0.36
2014 Thompson JL, Rosell DR, Slifstein M, Girgis RR, Xu X, Ehrlich Y, Kegeles LS, Hazlett EA, Abi-Dargham A, Siever LJ. Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112. Psychopharmacology. 231: 4231-40. PMID 24781514 DOI: 10.1007/s00213-014-3566-6  0.36
2013 Poels EM, Girgis RR, Thompson JL, Slifstein M, Abi-Dargham A. In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacology. 228: 167-74. PMID 23460265 DOI: 10.1007/s00213-013-3026-8  0.36
2013 Thompson JL, Urban N, Slifstein M, Xu X, Kegeles LS, Girgis RR, Beckerman Y, Harkavy-Friedman JM, Gil R, Abi-Dargham A. Striatal dopamine release in schizophrenia comorbid with substance dependence Molecular Psychiatry. 18: 909-915. PMID 22869037 DOI: 10.1038/mp.2012.109  0.36
2013 Thompson JL, Urban N, Slifstein M, Xu X, Kegeles LS, Girgis RR, Beckerman Y, Harkavy-Friedman JM, Gil R, Abi-Dargham A. Striatal Dopamine Release in Schizophrenia Comorbis with Substance Dependence Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 152-153. DOI: 10.1016/B978-0-12-800044-1.00135-5  0.36
2012 Sugranyes G, Thompson JL, Corcoran CM. HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis. Journal of Psychiatric Research. 46: 1389-93. PMID 22892058 DOI: 10.1016/j.jpsychires.2012.07.011  0.36
2012 Urban NB, Slifstein M, Thompson JL, Xu X, Girgis RR, Raheja S, Haney M, Abi-Dargham A. Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biological Psychiatry. 71: 677-83. PMID 22290115 DOI: 10.1016/j.biopsych.2011.12.018  0.36
2012 Abi-Dargham A, Xu X, Thompson JL, Gil R, Kegeles LS, Urban N, Narendran R, Hwang DR, Laruelle M, Slifstein M. Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: A PET study with [11C]NNC112 Journal of Psychopharmacology. 26: 794-805. PMID 21768159 DOI: 10.1177/0269881111409265  0.36
2010 Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T, Harkavy-Friedman JM, Gil R, Laruelle M, Abi-Dargham A. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography. Biological Psychiatry. 68: 634-41. PMID 20673873 DOI: 10.1016/j.biopsych.2010.05.027  0.36
2010 Slifstein M, Kegeles LS, Xu X, Thompson JL, Urban N, Castrillon J, Hackett E, Bae SA, Laruelle M, Abi-Dargham A. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride. Synapse (New York, N.Y.). 64: 350-62. PMID 20029833 DOI: 10.1002/syn.20734  0.36
2009 Thompson JL, Kelly M, Kimhy D, Harkavy-Friedman JM, Khan S, Messinger JW, Schobel S, Goetz R, Malaspina D, Corcoran C. Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis. Schizophrenia Research. 108: 176-81. PMID 19174322 DOI: 10.1016/j.schres.2008.12.005  0.36
2005 Thompson JL, Watson JR, Steinhauer SR, Goldstein G, Pogue-Geile MF. Indicators of genetic liability to schizophrenia: a sibling study of neuropsychological performance. Schizophrenia Bulletin. 31: 85-96. PMID 15888428 DOI: 10.1093/schbul/sbi009  0.36
2004 Thompson JL, Pogue-Geile MF, Grace AA. Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms. Schizophrenia Bulletin. 30: 875-900. PMID 15954196  0.36
Show low-probability matches.